The inaugural Guangzhou International Biopharmaceutical Industry Conference was held from May 25 to 27 in Guangzhou's Huangpu district.
The Guangzhou Urban Innovation Index Report (2022) was released on March 3.
The 2022 (8th) Industrial Match-making Conference for Advanced Technology Application and Industrialization Development was held in Huangpu district, Guangzhou, on Dec 27.
A striking tire-shaped building in Xinlong town, Huangpu district is the site of the Aviation Tire Science Center.
Huangpu district was recently selected as a municipal-level pilot area of "Science and Technology Innovation China" in Guangzhou.
Hongsing Seed Valley, a tourism destination in the Guangzhou Development District (GDD), has an exhibition hall measuring more than 2,600 square meters, a high-tech experience hall, and a scientific museum.
Cadonilimab (PD-1/CTLA-4), the first dual immune checkpoint inhibitor to treat cancer in the world that was developed by Huangpu-based biopharmaceutical company Akeso, was put on the market on July 9.
Six unmanned luncheon cars have started licensed operation around Guangzhou International Bio Island in Huangpu district, local media outlets reported on April 8.
China has granted approval to five COVID-19 antigen test kits made by local companies to be used for self-testing as a way to beef up early detection capabilities to cope with the more evasive and transmissible Omicron variant.
Guangzhou's Huangpu district has taken the lead in the country in marking local historic sites and cultural relics on Baidu Map.